본문바로가기
Q
U
I
C
K

PR

SK bioscience company news updates

Media Zoom

[Korean Vaccine No. 1] ‘Lead by Example’ CEO Ahn Jae-yong, ‘SKYCovione’ as Fourth Vaccination

2022.09.19


 

Mr Ahn Jae-yong, CEO of SK Bioscience (SK Bio), was vaccinated using ‘SKYCovione’, the first Korean Covid-19 vaccine developed by SK Bio as ‘leading by example’.

According to SK Bio, Mr Ahn visited Hansarang Kim Gyeong-hee Pediatrics in Bundang, Gyeonggi-do and was vaccinated with SKYCovione on September 19
SKYCovione is a Covid-19 vaccine that SK Bio has developed based on its global network.